The nationwide personal-injury resolution requires Bayer to disburse funds ranging from $10,000 to $165,000 per claimant based on occupational exposure and diagnostic age. This agreement builds upon a previous deal where the company paid between $10 billion and $11 billion to settle over 100,000 lawsuits. While Bayer removed glyphosate from American residential products, the weed-killer remains widely utilized in the agricultural sector. Meanwhile, the Environmental Protection Agency is continuing to review human health evidence regarding the chemical.
Key points
Bayer continues to maintain that its primary herbicide ingredient does not cause cancer d…: Bayer continues to maintain that its primary herbicide ingredient does not cause cancer despite paying out billions.
The company removed glyphosate from its United States residential market while maintainin…: The company removed glyphosate from its United States residential market while maintaining its active use in agriculture.
Regulatory agencies remain divided as the EPA reviews evidence and the World Health Organ…: Regulatory agencies remain divided as the EPA reviews evidence and the World Health Organization views glyphosate as probably carcinogenic.
Sources checked by our analysis pipeline: 1
The agrochemical and biotech giant Bayer has agreed to pay billions of dollars to people who sued the company alleging the weed-killer Roundup caused their cancer.
On Friday, a judge in Missouri gave final approval to the nationwide settlement that could cost the company up to $7.25 billion in the coming years.
The money will go to thousands of people who have been or will be diagnosed with non-Hodgkin lymphoma — a blood cancer that they claim is linked to glyphosate, which is the main ingredient in Roundup.
Under the settlement in circuit court, people affected could receive anywhere from $10,000 to $165,000 in compensation, depending on whether their work in agriculture or other occupations exposed them to higher levels of glyphosate, the age when they were diagnosed with non-Hodgkin lymphoma and other factors.
In a statement, the CEO of Bayer, Bill Anderson, called the settlement a "decisive milestone" that will "mitigate the risks" of pending and future litigation.
The presiding judge, Timothy Boyer, said it was "among the largest in the history of mass tort personal-injury class action settlements."
The quiet departure highlights the growing risks buyers face as smaller automotive distributors struggle to maintain viable footprints in Singapore's competitive market. Following the earlier collapse of Neta, the shutdown leaves dozens of saloon owners stranded without dealership-backed warranty packages or official servicing channels. While routine physical repairs remain possible through independent shops, drivers face severe challenges obtaining critical factory software updates.
Across the country, consumers are aggressively stocking up on survival goods following high-profile infrastructure failures and government preparedness messaging. Retail data shows high-priced generators and staple pantry items are rapidly selling out, highlighting elevated public anxiety about systemic grid and technology vulnerabilities. While warehouses pause for their standard annual holiday schedule, the broader buying patterns reflect deeper consumer concerns over national stability.
An international buyer swiftly closed on the premier boutique residence to secure full-service hospitality amenities while strategically bypassing neighboring municipal property fees. The high-profile transaction sets a new luxury benchmark for local condominium sales despite trading at a steep discount from its original valuation. It demonstrates sustained demand among overseas ultra-high-net-worth investors seeking standalone municipal tax shelters within premier Los Angeles enclaves.